Pigment dispersion is a condition where tiny granules of pigment flake off from the back surface of the iris (the colored part of your eye) and float into the fluid inside the eye. These loose pigment particles then settle on various structures, including the drainage system that controls eye pressure. Most people with pigment dispersion have no symptoms and never develop vision problems, but roughly 10 to 15% eventually develop a form of glaucoma that requires treatment.
How Pigment Gets Released
The back surface of your iris is lined with a layer of pigmented cells. In some eyes, the iris bows slightly backward instead of sitting flat, pushing it into contact with the tiny fibers (called zonules) that hold the lens in place just behind it. Every time your pupil dilates and constricts, the back of the iris rubs against these fibers like sandpaper. That repeated friction scrapes off melanin pigment granules, releasing them into the fluid that circulates through the front of the eye.
This backward bowing of the iris is sometimes called “reverse pupillary block.” It happens because a small pressure difference develops between the front and back chambers of the eye, pushing the iris into a concave shape. Eyes that are moderately nearsighted tend to have more room behind the iris, which makes this contact more likely. That’s one reason the condition clusters in people with myopia averaging around -3 to -4 diopters.
Who Gets It
Pigment dispersion syndrome (PDS) is most often found in young, nearsighted men in their 20s and 30s, though women develop it too, typically about a decade later in their 40s. The male-to-female ratio for the syndrome itself is close to even, but men are significantly more likely to progress to the glaucoma stage, where ratios range from 2-to-1 up to 5-to-1. It is more frequently diagnosed in people of European descent, though it also occurs in Black patients, often at younger ages.
Many people are completely unaware they have PDS. It’s often caught incidentally during a routine eye exam when an eye doctor notices characteristic pigment deposits or iris changes through a slit lamp.
What Your Eye Doctor Sees
Pigment dispersion leaves a recognizable pattern of signs inside the eye. The most commonly observed finding, present in about 85% of patients, is heavy pigment deposited in the trabecular meshwork, the tiny drainage channels that sit in the angle where the iris meets the cornea. Your doctor views this using a mirrored lens placed on the eye in a procedure called gonioscopy.
Another classic sign is the Krukenberg spindle: a vertical streak of pigment granules on the inner surface of the cornea, concentrated toward the bottom. Convection currents in the eye’s fluid carry the pigment in a specific pattern, depositing it in this distinctive spindle shape. Your doctor can also look for iris transillumination defects, spots where pigment has been rubbed away from the iris so thoroughly that light passes through it in a spoke-like pattern. Pigment can also accumulate on the lens capsule in characteristic lines and deposits.
When symptoms do occur, they can include glare, halos around lights, mild eye pain, redness, and light sensitivity. These tend to flare after activities that cause rapid or repeated pupil movement.
Exercise and Pigment Showers
Vigorous physical activity can trigger an acute release of pigment, sometimes called a “pigment shower.” Activities that cause rapid pupil changes or physical jarring, like running, basketball, or heavy weightlifting, increase the friction between the iris and lens zonules. The burst of released pigment temporarily clogs the eye’s drainage channels, causing a short-term spike in eye pressure. Some people notice blurry vision or halos after intense exercise for this reason. The pressure rise is usually temporary, but repeated spikes over time may contribute to damage.
Risk of Developing Glaucoma
The central concern with pigment dispersion is whether it will progress to pigmentary glaucoma, where the pigment buildup in the drainage system raises eye pressure enough to damage the optic nerve. A long-term study tracking 113 patients over 24 years in Olmsted County, Minnesota found that 10% developed pigmentary glaucoma within 5 years and 15% within 15 years. That means the large majority of people with PDS never develop glaucoma, but the risk is real enough to warrant regular monitoring.
Interestingly, pigment release tends to slow with age. As the lens grows thicker over the decades, it pushes the iris forward, reducing the backward bowing and the contact that causes friction. Some people see their pigment dispersion essentially “burn out” by their 50s or 60s. However, damage to the drainage system that has already occurred doesn’t reverse, so eye pressure problems can persist or emerge even after active pigment shedding stops.
How It’s Monitored
If you’ve been diagnosed with PDS, your eye doctor will check your eye pressure, examine the optic nerve, and periodically test your visual field to look for any early signs of glaucoma. When pressure is stable and no damage is detected, visits are typically every 6 to 12 months. If there are signs of progression or pressure isn’t well controlled, follow-ups become more frequent, sometimes every one to two months until things stabilize. Your doctor may also use gonioscopy periodically to assess how much pigment is accumulating in the drainage angle.
Treatment Options
PDS without elevated pressure or optic nerve damage doesn’t require treatment beyond regular monitoring. When eye pressure rises or glaucoma develops, the approach is similar to other forms of open-angle glaucoma: the goal is lowering pressure to protect the optic nerve.
Prostaglandin analog eye drops are the most common first-line treatment. They work by increasing fluid drainage from the eye through an alternative pathway. A randomized trial found that once-daily prostaglandin drops provided better pressure control over one year than twice-daily beta blocker drops, with fewer side effects. Other medication classes used include beta blockers, carbonic anhydrase inhibitors, and newer options like rho kinase inhibitors.
An older drug called pilocarpine was once a go-to choice because it constricts the pupil and pulls the iris forward, directly reducing the friction that causes pigment release. In theory, it addresses the root mechanical problem. In practice, it causes enough side effects (headaches, blurred vision, accommodative spasm, and a possible increased risk of retinal detachment in already myopic eyes) that it’s rarely prescribed today.
Laser Iridotomy
Laser peripheral iridotomy creates a tiny hole in the iris to equalize pressure between the front and back chambers of the eye. By eliminating the pressure difference, the iris flattens out and stops bowing backward, which reduces its contact with the lens zonules. Clinical trials have shown that the procedure does flatten the iris configuration, but there isn’t yet strong evidence proving it prevents long-term visual field loss. It remains an option your doctor may discuss, particularly if your iris is markedly concave on imaging.